NAUTILUS BIOTECHNOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.49 USD | +5.51% |
|
+1.22% | -16.72% |
| 02-28 | Transcript : Nautilus Biotechnology, Inc., Q4 2023 Earnings Call, Feb 28, 2024 | |
| 02-28 | Nautilus Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 2.610 | 2.760 | 3.980 |
| Spread/Res. | -4.60% | -9.78% | -37.44% |
| Spread/Supp. | +6.41% | +6.41% | +7.79% |
| Support | 2.340 | 2.340 | 2.310 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- NAUT Stock
- Charts Nautilus Biotechnology, Inc.
